Author name: David Lambert

Dr Lambert is a principal, managing partner and chief informatics officer of CE Dojo, and former affiliate consultant to Old Well Consulting responsible for their eLearning platform. Dr Lambert is a Diplomate of the American Board of Oral & Maxillofacial Surgery and former clinical pharmacist. Dr Lambert is former Assistant Professor of Oral & Maxillofacial Surgery at the Oregon Health & Sciences University in Portland, Oregon where he also studied Clinical Informatics within the Department of Medical Informatics and Clinical Epidemiology. Dr Lambert has lectured extensively on topics of surgery, pharmacology, the opiate crisis and is published within several peer-reviewed journals.

New Study: 4th Wave Of Opiate Crisis Skyrockets

A recent study published in Addiction examined polysubstance overdose deaths in the United States during the transition to the fourth wave of the drug overdose crisis. The researchers analyzed national death records from 2010 to 2021 and found an over 50 fold increase in overdose deaths involving both fentanyl and stimulants, with the most substantial …

New Study: 4th Wave Of Opiate Crisis Skyrockets Read More »

Socratic Dental Alliance Op Ed: Exposing False Narratives and Health Concerns of COVID Crisis

We are fortunate as both clinicians and Americans to have a hero of exponential proportions amongst us.  For those who have not heard of Dr. Peter McCullough, he is a practicing cardiologist, epidemiologist and internist.  He is one of the most published cardiologists (over 1000 publications and 685 citations in the National Library of Medicine) …

Socratic Dental Alliance Op Ed: Exposing False Narratives and Health Concerns of COVID Crisis Read More »

Is Wastewater Sampling The New Dumpster Diving?

Researchers from Boston College, Boston University, and Giner Labs have developed a groundbreaking penny-sized biosensor using atom-thick graphene. This innovative device, described in ACS Nano, is the first to utilize graphene-based field effect transistors for detecting four different opioids simultaneously in wastewater, addressing a key challenge in understanding opioid usage within communities. When an opioid …

Is Wastewater Sampling The New Dumpster Diving? Read More »

The UK Personal Independence Payment Database – Should Spiraling Disabilities Give Pause To Reconsider Continued Routine Office Based Anesthesia In Dentistry Without Further Consideration?

Former Blackrock hedge fund analyst Ed Dowd made a troubling discovery about mortality rates in the US. He observed an increase in deaths, particularly among young individuals, unrelated to COVID-19. Insurance companies also reported higher death rates. Dowd’s research team has now found startling data from the UK indicating a significant rise in disabilities coinciding with the mass vaccination effort. Dowd believes the same trend is likely happening in the US. This raises concerns, especially in dentistry, where an increase in cardiovascular disabilities among young patients has been observed. A more cautious approach to office-based anesthesia may be necessary.

Fluoride: A Second Look…

Many of us learned about the advantages of fluoride in dental school. However, in the post-COVID pandemic era, people are reevaluating widely accepted beliefs, including fluoride. Anti-fluoridation proponents have presented valid arguments.   Join the Socratic Dental Alliance and watch a video of a recent meeting with two notable advocates, Rick North and Barbara Tritz, to …

Fluoride: A Second Look… Read More »

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners

The US Drug Enforcement Administration (DEA) has outlined an eight-hour training requirement on the treatment and management of opioid patients. The Medication Access and Training Expansion Act mandates the training for all DEA-registered providers, with the deadline for completion set for the date of a practitioner’s next scheduled DEA registration submission beginning on June 27. Graduates from medical and dental schools are exempt from the requirement. The training does not have to occur in one session, and courses previously undertaken in accordance with state-mandated continuing education will apply.

FDA Approves OTC Naloxone

This article discusses the recent approval of the first over-the-counter naloxone nasal spray for use in reversing opioid overdoses. The U.S. Food and Drug Administration (FDA) has approved the first over-the-counter (OTC) naloxone nasal spray, Narcan, to help prevent opioid overdoses. The nasal spray is intended for use in adults and adolescents, and the FDA …

FDA Approves OTC Naloxone Read More »

Shopping Cart
Scroll to Top